← Browse by Condition
Medical Condition

hemophagocytic lymphohistiocytoses

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2
NCT05882175
Recruiting

Prospective Validation of the OHI Index

Enrollment
300 pts
Location
Israel
Sponsor
Meir Medical Center
View Trial →
NCT06585124
Recruiting

Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas

Enrollment
150 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT03117010
Recruiting

Prospective Cohort for Adult Hemophagocytosis

Enrollment
81 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →
NCT06160791 Phase 2
Recruiting

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

Enrollment
36 pts
Location
United States
Sponsor
Jerry Lee, MD, MSc, MPhil
View Trial →